1. Home
  2. CSL vs ROIV Comparison

CSL vs ROIV Comparison

Compare CSL & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

N/A

Current Price

$352.68

Market Cap

17.1B

Sector

Industrials

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$29.83

Market Cap

20.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSL
ROIV
Founded
1917
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1B
20.7B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CSL
ROIV
Price
$352.68
$29.83
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$393.33
$27.56
AVG Volume (30 Days)
380.2K
5.2M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
1.25%
N/A
EPS Growth
N/A
N/A
EPS
17.12
N/A
Revenue
$5,003,600,000.00
$29,053,000.00
Revenue This Year
$2.21
N/A
Revenue Next Year
$4.25
$385.85
P/E Ratio
$20.64
N/A
Revenue Growth
9.08
N/A
52 Week Low
$293.43
$8.73
52 Week High
$435.92
$30.30

Technical Indicators

Market Signals
Indicator
CSL
ROIV
Relative Strength Index (RSI) 31.87 67.89
Support Level $344.01 $20.46
Resistance Level $398.08 N/A
Average True Range (ATR) 12.84 0.93
MACD -7.67 -0.01
Stochastic Oscillator 18.87 86.76

Price Performance

Historical Comparison
CSL
ROIV

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: